Clinical Trial Update: Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 multiple ascending dose trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7126209 (Brainshuttle AD) following …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RO7126209

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Alzheimers Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING